Literature DB >> 28939030

Positive Blood Cultures in Periprosthetic Joint Infection Decrease Rate of Treatment Success.

Mitchell R Klement1, Ahmed Siddiqi2, Justin M Rock3, Antonia F Chen3, Michael P Bolognesi4, Thorsten M Seyler4.   

Abstract

BACKGROUND: Blood cultures are often obtained at the time of periprosthetic joint infection (PJI) diagnosis yet they are not considered part of the diagnostic criteria and the effects of a positive result on surgical outcome are unknown. The purposes of this study are to characterize the use of blood cultures when diagnosing PJI and to determine the association of positive blood cultures with PJI treatment success.
METHODS: A retrospective chart review on 320 patients surgically treated for primary hip and knee PJIs was performed from 2006-2013 at 2 academic medical centers with minimum 12-month follow-up. Treatment success was defined by the Delphi criteria. Multiple logistic regression analysis was performed to identify variables associated with treatment success.
RESULTS: Blood cultures were obtained from 53.1% of PJI patients (170/320) at the time of diagnosis. The same organism was identified 86.0% of the time in blood culture and operative culture. Patients with positive blood cultures at the time of PJI diagnosis had elevated synovial white blood cell count (98,979, P = .012), elevated serum C-reactive protein (24.2 mg/L, P < .001), and decreased treatment success (65.1%) compared with those with a negative blood culture (85.0%) and those without a blood culture (82.7%, P = .013). A positive blood culture remained associated with decreased PJI treatment success using multiple logistic regression analysis.
CONCLUSION: The presence of positive blood cultures at the time of PJI diagnosis decreased PJI treatment success. Further prospective studies are needed to help identify the role of blood cultures in the work up of PJI and treatment optimization in these patients.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  arthroplasty; blood cultures; complications; infection; level III; outcome; periprosthetic joint infection

Mesh:

Year:  2017        PMID: 28939030     DOI: 10.1016/j.arth.2017.08.034

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  4 in total

Review 1.  New Innovations in the Treatment of PJI and Biofilms-Clinical and Preclinical Topics.

Authors:  Mariam Taha; Hesham Abdelbary; F Patrick Ross; Alberto V Carli
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

2.  For Patients With Acute PJI Treated With Debridement, Antibiotics, and Implant Retention, What Factors Are Associated With Systemic Sepsis and Recurrent or Persistent Infection in Septic Patients?

Authors:  Leanne Ludwick; Marcelo Siqueira; Noam Shohat; Matthew B Sherman; Sydney Streicher; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2022-04-14       Impact factor: 4.755

3.  Is Procalcitonin (PCT) a reliable biomarker for preoperative diagnosing of low grade periprosthetic joint infection? A prospective study.

Authors:  André Busch; Marcus Jäger; Harald Engler; Marcel Haversath; Charlotte Bielefeld; Stefan Landgraeber; Alexander Wegner
Journal:  BMC Musculoskelet Disord       Date:  2020-04-20       Impact factor: 2.362

4.  Bacteremia in Patients Undergoing Debridement, Antibiotics, and Implant Retention Leads to Increased Reinfections and Costs.

Authors:  Samuel Rosas; Vishal Hegde; F Johannes Plate; Douglas Dennis; Jason Jennings; Daniel N Bracey
Journal:  Arthroplast Today       Date:  2022-07-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.